VCC-1在胰腺癌组织中的表达及意义
2021-03-25宋剑锋白明辉
宋剑锋 白明辉





【摘要】 目的:探討血管内皮生长因子相关性趋化因子-1(VCC-1)在胰腺癌组织中的表达及意义。方法:应用免疫组织化学方法测定VCC-1在52例胰腺癌及52例对应癌旁正常胰腺组织中的表达情况,并分析VCC-1和胰腺癌临床相关指标之间的关系。结果:VCC-1蛋白在胰腺癌组织中阳性表达率为76.92%高于癌旁组织的28.85%,差异有统计学意义(P<0.05)。VCC-1在Ⅰ、Ⅱ期胰腺癌组织的阳性表达率为69.23%(27/39)低于Ⅲ期的100%(13/13),差异有统计学意义(P<0.05)。VCC-1在有淋巴结转移的阳性表达率为91.67%(22/24)高于无淋巴结转移的64.29%(18/28),差异有统计学意义(P<0.05)。VCC-1在肿瘤直径≤2 cm中的阳性表达率为60.71%(17/28),低于肿瘤直径>2 cm的95.83%(23/24),差异有统计学意义(P<0.05)。VCC-1在低分化癌中的阳性表达率为83.33%(10/12),在中分化癌中的阳性表达率为87.88%(29/33),在高分化中的阳性表达率为14.29%(1/7),差异有统计学意义(P<0.05)。VCC-1与患者的年龄、性别及肿瘤部位无关(P>0.05)。VCC-1阴性表达组PC患者的中位生存期为26.9个月长于阳性表达组的16.3个月,差异有统计学意义(P<0.05)。结论:VCC-1在胰腺癌组织中呈高表达,VCC-1的表达可能在胰腺癌的发生、发展中起重要作用。
【关键词】 胰腺肿瘤 血管内皮生长因子相关性趋化因子-1 肿瘤标记
Expression and Significance of VCC-1 in Pancreatic Cancer Tissue/SONG Jianfeng, BAI Minghui. //Medical Innovation of China, 2021, 18(23): -163
[Abstract] Objective: To investigate the expression and significance of VCC-1 in pancreatic cancer tissue. Method: The VCC-1 expressions in 52 specimens of pancreatic cancer tissues and 52 specimens of their adjacent normal pancreatic tissues were determined by immunohistochemical staining, and the relationship between VCC-1 and clinical indicators of pancreatic cancer were analyzed. Result: The positive expression rate of VCC-1
protein in pancreatic cancer tissues was 76.92%, higher than 28.85% in paracancer tissues, the difference was statistically significant (P<0.05). The positive expression rate of VCC-1 in stage Ⅰ, Ⅱ pancreatic cancer tissues was 69.23% (27/39), which was lower than 100% (13/13) in stage Ⅲ, the difference was statistically significant (P<0.05). The positive expression rate of VCC-1 with lymph node metastasis was 91.67% (22/24), which was higher than 64.29% (18/28) without lymph node metastasis, the difference was statistically significant (P<0.05). The positive expression rate of VCC-1 in tumor diameter ≤2 cm was 60.71% (17/28), which was lower than 95.83% (23/24) in tumor diameter >2 cm, the difference was statistically significant (P<0.05). The positive expression rate of VCC-1 in low differentiation carcinoma was 83.33% (10/12), the positive expression rate of VCC-1 in medium differentiation carcinoma was 87.88% (29/33), and the positive expression rate of VCC-1 in high differentiation carcinoma was 14.29% (1/7), the difference was statistically significant (P<0.05). VCC-1 was not associated with age, gender or tumor site (P>0.05). The median survival time of PC patients in VCC-1 negative expression group was 26.9 months, which was longer than 16.3 months in positive expression group, the difference was statistically significant (P<0.05). Conclusion: The VCC-1 expression is increased in pancreatic cancer and its expression may be closely connected to the occurrence and development of pancreatic cancer.
[Key words] Pancreatic neoplasms VEGF correlated chemokine-1 Tumor markers
First-author’s address: Foresea Life Insurance Guangzhou General Hospital, Guangzhou 511300, China
doi:10.3969/j.issn.1674-4985.2021.23.039
胰腺癌(pancreatic cancer,PC)早期症状不明显,且发展快,预后差,其5年生存率为8%,有淋巴结转移者5年生存率为3%[1-8]。目前PC被诊断时多为中晚期,手术切除是最有效的治疗方法,但复发率比较高[9-13]。而导致PC发生和进展是多种基因及因素共同作用的结果[14]。已经有研究表明血管内皮生长因子相关性趋化因子-1(vsacular endothelial growth factor correlated chemokine 1,VCC-1)與乳腺癌、直肠癌及肝细胞癌的发生、发展有关[15]。笔者通过试验研究VCC-1在PC中的表达及意义,现报道如下。……
